Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Revenue

In the fiscal year ending June 30, 2026, Alterity Therapeutics had annual revenue of 3.61M AUD, down -52.76%. Alterity Therapeutics had revenue of 806.59K in the half year ending June 30, 2026, a decrease of -61.93%.

• Revenue: 3.61M
• Revenue Growth: -52.76%
• P/S Ratio: 29.05
• Revenue / Employee: 328.18K
• Employees: 11
• Market Cap: 104.88M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	3.61M	-4.03M	-52.76%
Jun 30, 2025	7.64M	3.62M	90.12%
Jun 30, 2024	4.02M	102.95K	2.63%
Jun 30, 2023	3.92M	-1.21M	-23.56%
Jun 30, 2022	5.12M	638.30K	14.23%
Jun 30, 2021	4.49M	4.36M	3,554.58%
Jun 30, 2020	122.73K	-4.83M	-97.52%
Jun 30, 2019	4.95M	1.83M	58.40%
Jun 30, 2018	3.13M	103.10K	3.41%
Jun 30, 2017	3.02M	-1.87M	-38.27%
Jun 30, 2016	4.90M	-1.60M	-24.61%
Jun 30, 2015	6.49M	-1.71M	-20.89%
Jun 30, 2014	8.21M	3.57M	76.94%
Jun 30, 2013	4.64M	2.11M	83.56%
Jun 30, 2012	2.53M	2.36M	1,451.38%
Jun 30, 2011	162.92K	-52.09K	-24.23%
Jun 30, 2010	215.01K	-213.19K	-49.79%
Jun 30, 2009	428.19K	-62.92K	-12.81%
Jun 30, 2008	491.11K	-16.32K	-3.22%
Jun 30, 2007	507.44K	-542.85K	-51.69%
Jun 30, 2006	1.05M	-1.60M	-60.41%
Jun 30, 2005	2.65M	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 8, 2026

Data Sources Report a data error